For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Atyr Pharma, Inc.

USPTO Granted Patents = 92

CIPO Patents = 8

EPO Patents = 33

Trademarks = 1

Forward Citations = 710

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Leslie Ann Greene (74 out of 75 patents)

John D Mendlein (66 out of 86 patents)

Kyle P Chiang (65 out of 67 patents)

4. Jeffry Dean Watkins (65 out of 103 patents)

5. Fei Hong (61 out of 62 patents)

6. Wing-Sze Lo (60 out of 61 patents)

7. Alain Philippe Vasserot (59 out of 98 patents)

8. Cheryl L Quinn (54 out of 55 patents)

9. Kristi Helen Piehl (22 out of 22 patents)

10. Ryan Andrew Adams (14 out of 14 patents)

11. Zhiwen Xu (12 out of 12 patents)

12. Chi-Fang Wu (9 out of 9 patents)

13. Ying Buechler (9 out of 17 patents)

14. Ching-Fun Lau (8 out of 8 patents)

15. Jie Zhou (7 out of 8 patents)

Core Competencies:

Anti-NRP2 Antibodies

Histidyl-tRNA Synthetase

Aminoacyl tRNA Synthetases

PEGylated Polypeptides

Thrombopoietic Activity

Lung Inflammation Treatment

Non-Canonical Biological Activities

Protein Fragments

Diagnostic Compositions

Therapeutic Compositions

Inflammation Modulation

Cell Signaling Activity

92 patents: Sort by Forward Citations

1. 12410253 - Compositions comprising anti-NRP2 antibodies (2025-09-09),

2. 12065495 - Compositions and methods comprising anti-NRP2 antibodies (2024-08-20),

3. 11807687 - Therapeutic compositions comprising anti-NRP2 antibodies (2023-11-07),

4. 11767520 - Compositions and methods for treating lung inflammation (2023-09-26),

5. 11505610 - Compositions and methods comprising anti-NRP2 antibodies (2022-11-22),

6. 11078299 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-08-03),

7. 11072787 - Histidyl-tRNA synthetase-Fc conjugates (2021-07-27),

8. 10941214 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-03-09),

9. 10711260 - Histidyl-tRNA synthetase-Fc conjugates (2020-07-14),

10. 10669533 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases (2020-06-02),

11. 10563192 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases (2020-02-18),

12. 10563191 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases (2020-02-18),

13. 10526419 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2020-01-07),

14. 10472618 - Histidyl-tRNA synthetase-Fc conjugates (2019-11-12),

15. 10220080 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases (2019-03-05),

aTyr Pharma, Inc. is a biotechnology company focused on developing innovative protein-based therapeutics to treat severe autoimmune diseases and related disorders. Their unique approach involves harnessing the biology of extracellular tRNA synthetases to discover and develop novel therapeutics. With their expertise in protein science and immunology, aTyr Pharma aims to provide potential treatment options for patients with rare and severe autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

92 Patents

#68 in San Diego, CA

#934 in California

#3,919 in US

#8,106 in the World

San Diego, CA, United States of America

Atyr Pharma, Inc.

Forward Citations = 710

47 inventors:

Leslie Ann Greene (74 out of 75 patents)

John D Mendlein (66 out of 86 patents)

Kyle P Chiang (65 out of 67 patents)

4. Jeffry Dean Watkins (65 out of 103 patents)

5. Fei Hong (61 out of 62 patents)

Please report any incorrect information to support@idiyas.com

Loading…